Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. [electronic resource]
Producer: 20160609Description: 1994-1999 p. digitalISSN:- 1569-8041
- Antineoplastic Agents, Alkylating -- therapeutic use
- Brain Neoplasms -- drug therapy
- Colorectal Neoplasms -- drug therapy
- DNA -- blood
- DNA Methylation -- genetics
- DNA Modification Methylases -- genetics
- DNA Repair Enzymes -- genetics
- Dacarbazine -- analogs & derivatives
- Disease-Free Survival
- Glioblastoma -- drug therapy
- Humans
- Polymerase Chain Reaction
- Prognosis
- Promoter Regions, Genetic -- genetics
- Temozolomide
- Tumor Suppressor Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.